Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06159647 · ClinicalTrials.gov registry record · NA
Consumer Responses to Alcohol Warnings
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 2,522
- Enrollment target
NCT06159647: Completed NA study, sponsored by Stanford University.
NCT06159647 is a NA study that has completed, run by Stanford University. The registered enrollment target is 2,522 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06159647, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,522 participants
- Enrollment target
Study Summary
The primary objective is to evaluate whether alcohol warnings about different topics elicit higher perceived message effectiveness than control messages. The secondary objective is to evaluate whether alcohol warnings about different topics elicit higher reactance than control messages.
Primary Outcome
The study will assess perceived message effectiveness using 1 item: "How much does this message discourage you from wanting to drink alcohol?" Response options will range from "not at all" (coded as 1) to "a great deal" (coded as 5). Higher scores indicate more perceived message effectiveness.
Interventions
- BEHAVIORAL Mouth cancer warning
- BEHAVIORAL Throat cancer warning
- BEHAVIORAL Voice box (larynx) warning
- BEHAVIORAL Esophagus cancer warning
- BEHAVIORAL Liver cancer warning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,522 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2024-01-26 |
| Phase | NA |
What the finished NCT06159647 record still lists
NCT06159647 is an interventional study that assigns participants to a tested intervention. Its 2,522 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% higher).
The record links to 0 conditions, and to 5 interventions - of which Mouth cancer warning is the first listed.
NCT06159647 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06159647 about?
NCT06159647 is a clinical study titled "Consumer Responses to Alcohol Warnings". The primary objective is to evaluate whether alcohol warnings about different topics elicit higher perceived message effectiveness than control messages. The secondary objective is to evaluate whether alcohol warnings about different topics elicit higher reactance than control messages.
What is the current status of trial NCT06159647?
This trial is currently completed. It is a NA study. The enrollment target is 2,522 participants. The study started on 2024-01-18. Estimated completion is 2024-01-26.
What interventions are being tested in trial NCT06159647?
The interventions under investigation include: Mouth cancer warning (BEHAVIORAL), Throat cancer warning (BEHAVIORAL), Voice box (larynx) warning (BEHAVIORAL), Esophagus cancer warning (BEHAVIORAL), Liver cancer warning (BEHAVIORAL).
Who is sponsoring clinical trial NCT06159647?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06159647's enrollment target sits among peer trials
2,522 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04142177 · 2,529 participants · NA
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
- NCT00018057 · 2,530 participants · Phase 2
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- NCT05931276 · 2,540 participants · Phase 3
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI